Biocom today announced a distinguished keynote session for its 2026 Global Partnering & Investor Conference, taking place February 24 to 26 at The Lodge at Torrey Pines in La Jolla, California. This ...
Despite an unusual lack of major announcements, energy is high. And a few key themes dominate discussions.
For startups, every resource matters. Between product development, fundraising, and acquiring customers, business ...
The science pros at TKOR build a sonic cannon that blasts with real power. Donald Trump changes his mind on tariffs again Rob Gronkowski reveals he’s never spent any of his NFL salary Suspected ...
Invivyd, Inc. was recently added to both the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index, increasing its presence among publicly traded biotech peers. This twin index ...
BioMarin Chief Executive Officer Alexander Hardy said the transaction makes strategic sense given BioMarin's commercial footprint and manufacturing capabilities, particularly as both companies focus ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
One of the hotter areas of cancer drug research involves using a particular type of bispecific antibody as the backbone for therapeutic combinations intended to bring a multi-pronged attack to tumors.
Unleashing the Power of the Mind Through Neuralink The Revolutionary Potential You Need to Know About! New disclosures show Trump bought bonds affected by government policy changes The Standoff That ...
Dennis E. Gonzalez, Ret. Regional Director, U.S. Dept. of Health and Human Services Ret. Regional Director, U.S. Dept. of Health and Human Services Dennis’s storied legacy of steering our nation ...
U.K. biotech companies raised 46% less in the third quarter (Q3) of 2025 than in the previous quarter, at £187 million (US$249.3 million). The Q3 2025 figure was also in the shade compared to Q1 2025, ...